register

News & Trends - MedTech & Diagnostics

College of Surgeons appalled by government’s decision to continue elective surgery

Health Industry Hub | March 27, 2020 |

MedTech News: The National Cabinet, acting on the advice of the Australian Health Protection Principal Committee, extended the temporary suspension of elective surgery for private hospitals from 25 March to 1 April 2020.

The Royal Australasian College of Surgeons (RACS) is appalled by the federal government’s decision to extend the deadline for category 2 and 3 elective surgeries at private hospitals.

“We are disappointed to hear that hospitals are being asked to continue non-critical surgery at a time when we must be putting the safety of patients and staff first. The federal government has made a reversal of their previously sensible decision to cancel all elective surgery except for urgent cases.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

“We are seeing decision making that can only be described as putting commercial interests before patient safety. Many of our surgeons who work in private hospitals are appalled and refusing to operate on non-critical cases. We want to see leadership from the federal government that puts people’s safety first,” says RACS President Tony Sparnon.

Healthscope and Ramsay Health Care will be restarting elective surgery for this period, with the exemption of elective ENT and dental maxilla-facial surgery at Healthscope hospitals.

Every patient waiting for elective surgery is assessed as Category 1, 2 or 3 per the following definitions:

  • Category 1 – Needing treatment within 30 days. Has the potential to deteriorate quickly to the point where the patient’s situation may become an emergency.
  • Category 2 – Needing treatment within 90 days. Their condition causes pain, dysfunction or disability. Unlikely to deteriorate quickly and unlikely to become an emergency.
  • Category 3 – Needing treatment at some point in the next year. Their condition causes pain, dysfunction or disability. Unlikely to deteriorate quickly.

Customer engagement during COVID-19 when all fieldforce are grounded. Health Industry Hub combines expertise in delivering digital health content and measuring customer insights and engagement with 20+ years industry experience. Created by industry for industry. Contact us.


News & Trends - Pharmaceuticals

Did the Federal Budget deliver for health?

Did the Federal Budget deliver for health?

Health Industry Hub | March 26, 2025 |

Health is the Federal Government’s largest financial commitment outside social welfare, absorbing approximately 15% of taxpayer funds. Yet, tonight’s Budget […]

More


News & Trends - Pharmaceuticals

How can the government Close the Gap with forecasted decline in funding?

How can the government Close the Gap with forecasted decline in funding?

Health Industry Hub | March 26, 2025 |

The Federal Government will increase investment in First Nations health programs by just 2.8% to $1.4 billion in 2025-26 – […]

More


News & Trends - Biotechnology

Local biotech kicks off phase 3 trial for lung cancer combination therapy

Local biotech kicks off phase 3 trial for lung cancer combination therapy

Health Industry Hub | March 26, 2025 |

ASX-listed biotech company Immutep has reached a major milestone, announcing that the first patient has been successfully dosed in its […]

More


Medical and Science

Research on life support as government Budget fails to deliver critical funding

Research on life support as government Budget fails to deliver critical funding

Health Industry Hub | March 26, 2025 |

Stakeholders are voicing disappointment over the government’s Budget failure to at least maintain research funding in line with inflation. In […]

More


This content is copyright protected. Please subscribe to gain access.